Department of Nephrology, University of Naples Federico II, Naples, Italy.
J Nephrol. 2012 Jul-Aug;25(4):582-5. doi: 10.5301/jn.5000073.
Fabry disease is an X-linked lysosomal disease caused by mutations of the alpha-galactosidase A (GLA) gene at chromosome subband Xq22.1. To date, more than 600 genetic mutations have been identified to determine the nature and frequency of the molecular lesions causing the classical and milder variant phenotypes and for precise carrier detection. We report here a Fabry family (mother, son and daughter) where the alpha-galactosidase A defect was associated with a glucose-6-phosphate dehydrogenase (G6PD) deficiency. Mutation analysis revealed for the GLA gene the presence of a new mutation, i.e., a small deletion (c.452delA) on exon 3 and for the G6PD gene the presence of 2 mutations, p.V68M (G6PD Asahi, G6PD A+) and p.N126D (G6PD A+) on exon 3 and exon 4, respectively.
法布瑞氏病是一种 X 连锁溶酶体贮积病,由染色体 Xq22.1 亚带的α-半乳糖苷酶 A(GLA)基因突变引起。迄今为止,已经发现了 600 多种基因突变,以确定导致经典和较轻微变异表型的分子病变的性质和频率,并进行精确的携带者检测。我们在此报告一个法布瑞氏病家族(母亲、儿子和女儿),其中α-半乳糖苷酶 A 缺陷与葡萄糖-6-磷酸脱氢酶(G6PD)缺乏有关。基因突变分析显示 GLA 基因存在新突变,即外显子 3 上的小缺失(c.452delA),而 G6PD 基因存在 2 个突变,即外显子 3 和外显子 4 上的 p.V68M(G6PD Asahi,G6PD A+)和 p.N126D(G6PD A+)。